Marinomed Biotech AG (MARI.VI)

EUR 13.95

(0.0%)

Total Liabilities Summary of Marinomed Biotech AG

Marinomed Biotech AG's latest annual total liabilities in 2023 was 24.74 Million EUR , down -6.41% from previous year.
Marinomed Biotech AG's latest quarterly total liabilities in 2024 Q1 was 23.98 Million EUR , down -3.07% from previous quarter.
Marinomed Biotech AG reported annual total liabilities of 26.44 Million EUR in 2022, up 25.06% from previous year.
Marinomed Biotech AG reported annual total liabilities of 21.14 Million EUR in 2021, up 16.54% from previous year.
Marinomed Biotech AG reported quarterly total liabilities of 24.74 Million EUR for 2023 Q4, up 1.91% from previous quarter.
Marinomed Biotech AG reported quarterly total liabilities of 24.85 Million EUR for 2023 Q2, down -0.75% from previous quarter.

Annual Total Liabilities Chart of Marinomed Biotech AG (2023 - 2015)

Historical Annual Total Liabilities of Marinomed Biotech AG (2023 - 2015)

Year	Total Liabilities	Total Liabilities Growth
2023	24.74 Million EUR	-6.41%
2022	26.44 Million EUR	25.06%
2021	21.14 Million EUR	16.54%
2020	18.14 Million EUR	110.11%
2019	8.63 Million EUR	-59.89%
2018	21.53 Million EUR	49.97%
2017	14.35 Million EUR	89.58%
2016	7.57 Million EUR	5.09%
2015	7.2 Million EUR	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q1	23.98 Million EUR	-3.07%
2023 Q4	24.74 Million EUR	1.91%
2023 Q2	24.85 Million EUR	-0.75%
2023 Q3	24.28 Million EUR	-2.29%
2023 Q1	25.04 Million EUR	-5.3%
2023 FY	24.74 Million EUR	-6.41%
2022 FY	26.44 Million EUR	25.06%
2022 Q4	26.44 Million EUR	-3.06%
2022 Q3	27.27 Million EUR	1.03%
2022 Q2	27 Million EUR	2.27%
2022 Q1	26.4 Million EUR	24.86%
2021 FY	21.14 Million EUR	16.54%
2021 Q2	17.17 Million EUR	-2.29%
2021 Q4	21.14 Million EUR	15.32%
2021 Q3	18.33 Million EUR	6.75%
2021 Q1	17.57 Million EUR	-3.11%
2020 Q3	10.99 Million EUR	10.92%
2020 Q2	9.91 Million EUR	13.19%
2020 Q1	8.75 Million EUR	1.42%
2020 FY	18.14 Million EUR	110.11%
2020 Q4	18.14 Million EUR	65.01%
2019 FY	8.63 Million EUR	-59.89%
2019 Q4	8.63 Million EUR	116.82%
2019 Q3	3.98 Million EUR	49.11%
2019 Q2	2.67 Million EUR	-59.0%
2019 Q1	6.51 Million EUR	-69.74%
2018 Q4	21.53 Million EUR	48.48%
2018 FY	21.53 Million EUR	49.97%
2018 Q3	14.5 Million EUR	0.0%
2017 Q4	14.35 Million EUR	0.0%
2017 FY	14.35 Million EUR	89.58%
2016 FY	7.57 Million EUR	5.09%
2015 FY	7.2 Million EUR	0.0%

Peer Total Liabilities Comparison of Marinomed Biotech AG

Name	Total Liabilities	Total Liabilities Difference